Childhood acute lymphoblastic leukaemia (cALL) accounts for about one third of all paediatric malignancies making it the most common cancer in children. Alterations tumour cell metabolism were first described nearly a century ago and have been acknowledged as key characteristics cancers including cALL. Two backbone chemotherapeutic agents treatment this disease, Glucocorticoids L-asparaginase, ...